Trial · NCT02150967
Adverse events555
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 555
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anaemia | Blood and lymphatic system disorders | Cohort 1: FGFR2 Fusions | 20 | 108 | |
| other | Anaemia | Blood and lymphatic system disorders | Cohort 2: Other FGFR Genetic Alterations | 5 | 25 | |
| other | Anaemia | Blood and lymphatic system disorders | Cohort 3: FGFR2 Fusions and Prior FGFR Inhibitor | 0 | 10 | |
| other | Thrombocytopenia | Blood and lymphatic system disorders | Cohort 1: FGFR2 Fusions | 9 | 108 | |
| other | Thrombocytopenia | Blood and lymphatic system disorders | Cohort 2: Other FGFR Genetic Alterations | 2 | 25 | |
| other | Thrombocytopenia | Blood and lymphatic system disorders | Cohort 3: FGFR2 Fusions and Prior FGFR Inhibitor | 0 | 10 | |
| other | Lymphopenia | Blood and lymphatic system disorders | Cohort 1: FGFR2 Fusions | 7 | 108 | |
| other | Lymphopenia | Blood and lymphatic system disorders | Cohort 2: Other FGFR Genetic Alterations | 1 | 25 | |
| other | Lymphopenia | Blood and lymphatic system disorders | Cohort 3: FGFR2 Fusions and Prior FGFR Inhibitor | 0 | 10 | |
| other | Neutropenia | Blood and lymphatic system disorders | Cohort 1: FGFR2 Fusions | 7 | 108 | |
| other | Neutropenia | Blood and lymphatic system disorders | Cohort 2: Other FGFR Genetic Alterations | 0 | 25 | |
| other | Neutropenia | Blood and lymphatic system disorders | Cohort 3: FGFR2 Fusions and Prior FGFR Inhibitor | 0 | 10 | |
| other | Dry eye | Eye disorders | Cohort 1: FGFR2 Fusions | 39 | 108 | |
| other | Dry eye | Eye disorders | Cohort 2: Other FGFR Genetic Alterations | 3 | 25 | |
| other | Dry eye | Eye disorders | Cohort 3: FGFR2 Fusions and Prior FGFR Inhibitor | 4 | 10 | |
| other | Vision blurred | Eye disorders | Cohort 1: FGFR2 Fusions | 23 | 108 | |
| other | Vision blurred | Eye disorders | Cohort 2: Other FGFR Genetic Alterations | 4 | 25 | |
| other | Vision blurred | Eye disorders | Cohort 3: FGFR2 Fusions and Prior FGFR Inhibitor | 1 | 10 | |
| other | Lacrimation increased | Eye disorders | Cohort 1: FGFR2 Fusions | 13 | 108 | |
| other | Lacrimation increased | Eye disorders | Cohort 2: Other FGFR Genetic Alterations | 2 | 25 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02150967/events